ACIM
PFE icon

Azimuth Capital Investment Management’s Pfizer PFE Stock Holding History

Azimuth Capital Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.6M Sell
398,549
-3,298
-0.8% -$86.3K 0.32% 103
2026
Q1 		$11.3M Buy
401,847
+20,888
+5% +$556K 0.42% 82
2025
Q4 		$9.49M Buy
380,959
+20,283
+6% +$511K 0.34% 105
2025
Q3 		$9.19M Sell
360,676
-2,564
-0.7% -$63.3K 0.33% 103
2025
Q2 		$8.8M Sell
363,240
-105,812
-23% -$2.47M 0.33% 113
2025
Q1 		$11.9M Sell
469,052
-2,323
-0.5% -$60.8K 0.47% 61
2024
Q4 		$12.5M Sell
471,375
-2,983
-0.6% -$80.9K 0.49% 60
2024
Q3 		$13.7M Sell
474,358
-3,094
-0.6% -$90.3K 0.53% 51
2024
Q2 		$13.4M Sell
477,452
-6,620
-1% -$182K 0.54% 51
2024
Q1 		$13.4M Buy
484,072
+685
+0.1% +$19K 0.55% 55
2023
Q4 		$13.9M Sell
483,387
-34,884
-7% -$1.05M 0.63% 55
2023
Q3 		$17.2M Buy
518,271
+1,485
+0.3% +$52.5K 0.85% 34
2023
Q2 		$19M Sell
516,786
-5,120
-1% -$199K 0.9% 25
2023
Q1 		$21.3M Sell
521,906
-2,050
-0.4% -$88.5K 1.05% 17
2022
Q4 		$26.8M Sell
523,956
-5,587
-1% -$268K 1.36% 8
2022
Q3 		$23.2M Sell
529,543
-10,596
-2% -$515K 1.27% 13
2022
Q2 		$28.3M Buy
+540,139
New +$27.5M 1.43% 9

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Azimuth Capital Investment Management's PFE Position: Q2 2026 in Review

Azimuth Capital Investment Management reduced its Pfizer (PFE) stake by 0.82% in Q2 2026, selling an estimated $86.3K and leaving 398,549 shares worth $9.6M. The position accounts for 0.32% of the portfolio, ranked #103.

Azimuth Capital Investment Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $28.3M in Q2 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Azimuth Capital Investment Management held 398,549 shares of Pfizer worth $9.6M as of Q2 2026.
  • Azimuth Capital Investment Management sold 3,298 Pfizer shares in Q2 2026, an estimated $86.3K.
  • Pfizer made up 0.32% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #103 holding.
  • Azimuth Capital Investment Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Azimuth Capital Investment Management's Pfizer position peaked at $28.3M in Q2 2022.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.